COMBIMAB Trademark

Trademark Overview


On Wednesday, April 21, 2004, a trademark application was filed for COMBIMAB with the United States Patent and Trademark Office. The USPTO has given the COMBIMAB trademark a serial number of 78405586. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, June 22, 2005. This trademark is owned by Epitomics, Inc.. The COMBIMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology services namely high-throughput generation of monoclonal antibodies
combimab

General Information


Serial Number78405586
Word MarkCOMBIMAB
Filing DateWednesday, April 21, 2004
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, June 22, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiotechnology services namely high-throughput generation of monoclonal antibodies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 30, 2004
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpitomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlingame, CA 940101303

Trademark Events


Event DateEvent Description
Wednesday, June 22, 2005ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, June 22, 2005ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, November 23, 2004NON-FINAL ACTION MAILED
Monday, November 22, 2004NON-FINAL ACTION WRITTEN
Monday, November 15, 2004ASSIGNED TO EXAMINER
Friday, April 30, 2004NEW APPLICATION ENTERED IN TRAM